SCHEMBL7798571

SCHEMBL7798571

CCOC(Cc1ccc(OCCOc2cccc3c2Cc2ccccc2C(=O)N3C)cc1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.59
PPARA Q07869 15/20 0.53
PPARD Q03181 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6724112 0.77 PPARG (0.59) PPARGPPARAPPARD
SCHEMBL6737303 0.77 PPARG (0.66) PPARGPPARAPPARD
SCHEMBL7529707 0.77 PPARG (0.78) PPARGPPARAPPARD
SCHEMBL6956717 0.76 PPARG (0.66) PPARGPPARAPPARD
SCHEMBL7533463 0.76 PPARG (0.78) PPARGPPARAPPARD
SCHEMBL7523772 0.74 PPARG (1.00) PPARGPPARAPPARD
SCHEMBL7040118 0.74 PPARG (0.68) PPARGPPARAPPARD
SCHEMBL6738244 0.73 PPARG (0.69) PPARGPPARAPPARD
SCHEMBL7528218 0.73 PPARG (0.92) PPARGPPARAPPARD
SCHEMBL27674855 0.73 PPARA (0.81) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010031762-A1 Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR) JEPPESEN LONE (DK) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031762-A1 Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR) PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.